# Colchicine in Patients With Mild and Severe Coronavirus Disease

> **NCT04367168** · PHASE2 · TERMINATED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 116 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04367168
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-05-27
- **Primary completion:** 2021-04-27
- **Final completion:** 2021-08-16
- **Target enrollment:** 116 (ACTUAL)
- **Why stopped:** The intervention was not effective for the outcomes
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367168, "Colchicine in Patients With Mild and Severe Coronavirus Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04367168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*